Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The age-related decline of helicase function-how G-quadruplex structures promote genome instability. | FEBS Lett | 2025 | 38803008 | PubTator, text mining | PubMed |
| Cancer Risk Assessment and Hereditary Cancer Genetic Testing in a Community OBGYN Setting. | Eur J Breast Health | 2024 | 41952566 | PubTator, text mining | PubMed |
| Evaluation of BRIP-1 (FANCJ) and FANCI Protein Expression in Ovarian Cancer Tissue. | Biomedicines | 2024 | 39767562 | PubTator, text mining | PubMed |
| BRCA2 germline mutation carrier with five malignancies: a case report. | Hered Cancer Clin Pract | 2024 | 39702187 | PubTator, text mining | PubMed |
| Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib. | Genome Med | 2024 | 39695768 | PubTator, text mining | PubMed |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. | Int J Mol Sci | 2024 | 39684258 | PubTator, text mining | PubMed |
| Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer. | JCO Precis Oncol | 2024 | 39666927 | PubTator, text mining | PubMed |
| The frequency of known germline LGR4 missense variant in the ethnic groups of West Siberia. | Mol Biol Rep | 2024 | 39644398 | PubTator, text mining | PubMed |
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma. | Front Oncol | 2024 | 39640282 | PubTator, text mining | PubMed |
| Genetic Testing and Analysis in Breast Cancer Patients in Greece. | Cureus | 2024 | 39624521 | PubTator, text mining | PubMed |
| BRIP1 Induced Ferroptosis to Inhibit Glioma Cells and was Associated with Increased Oxidative Stress. | Discov Med | 2024 | 39600281 | PubTator, text mining | PubMed |
| Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC. | JTO Clin Res Rep | 2024 | 39564094 | PubTator, text mining | PubMed |
| High Rates of Germline Pathogenic Variants in Somali Patients with Ovarian Cancer. | Gynecol Oncol Rep | 2024 | 39554377 | PubTator, text mining | PubMed |
| Germline pathogenic variants in prostate cancer. | Pathol Res Pract | 2024 | 39541765 | PubTator, text mining | PubMed |
| Splicing Dysregulation of Non-Canonical GC-5' Splice Sites of Breast Cancer Susceptibility Genes ATM and PALB2. | Cancers (Basel) | 2024 | 39518003 | PubTator, text mining | PubMed |
| Single-molecule insights into repetitive helicases. | J Biol Chem | 2024 | 39424144 | PubTator, text mining | PubMed |
| Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors. | Front Med (Lausanne) | 2024 | 39421870 | PubTator, text mining | PubMed |
| Understanding genetic variations associated with familial breast cancer. | World J Surg Oncol | 2024 | 39390525 | PubTator, text mining | PubMed |
| Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer. | Cancer Sci | 2024 | 39385713 | PubTator, text mining | PubMed |
| What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes ( ATM , BRIP1 , RAD51C , RAD51D , and PALB2 ). | Clin Obstet Gynecol | 2024 | 39324947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=10